Twin Capital Management Inc Bristol Myers Squibb CO Transaction History
Twin Capital Management Inc
- $875 Million
- Q4 2024
A detailed history of Twin Capital Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Twin Capital Management Inc holds 92,094 shares of BMY stock, worth $5.43 Million. This represents 0.6% of its overall portfolio holdings.
Number of Shares
92,094
Previous 82,849
11.16%
Holding current value
$5.43 Million
Previous $4.29 Million
21.48%
% of portfolio
0.6%
Previous 0.5%
Shares
31 transactions
Others Institutions Holding BMY
# of Institutions
2,763Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.2 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.36 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.67 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.61 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.56 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $125B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...